Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 601-329-8 | CAS number: 114798-26-4
The results for losartan potassium, which are read-across to losartan free acid, are summarised below. Maternal toxicity occurred in the form of three deaths and one abortion in the 40 mg/kg/day group, as well as depressions in maternal body weight gain and food consumption. In the 20 mg/kg/day group, there was one maternal death resulting in a no-effect dose for maternal toxicity of 10 mg/kg/day.
Developmental toxicity occurred in the form of decreased fetal body weight and delays in fetal ossification in the 40 mg/kg/day group resulting in a no-effect dose for developmental toxicity of 20 mg/kg/day.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Close Do not show this message again